Published May 22, 2014
| Version v1
Patent
Open
MODULATION OF CELL BARRIER DYSFUNCTION
Creators
- 1. University of Chicago
Contributors
Patent applicant:
Description
The invention provides prophylactic and therapeutic methods for administering a μ-opioid receptor antagonist, e.g., N-methylnaltrexone or a salt thereof, to treat cell barrier diseases and disorders, such as endothelial and epithelial cell barrier diseases and disorders, e.g., sepsis. Methods of reducing at least a symptom of sepsis and the risk of developing sepsis are also provided.
Files
US20140142133.pdf
Files
(4.0 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:cbaea9d38e4a076f222a2db6bc26383c
|
4.0 MB | Preview Download |
Additional details
Identifiers
- Patent number
- US 201314061331 A
- Patent application number
- US 2014/0142133 A1
- Other
- oai:uchicago.tind.io:8459
Dates
- Patent filed
-
2013-10-23